Life Science Compliance Update



It’s Not All About the Money – Medtronic’s Infusion Multi-State Settlement Agreement

Written by , Posted in Uncategorized

Robert N. Wilkey, Esq.

In a closely watched matter culminating years of litigation, Medtronic in December 2017, entered into a $12 Million multi-state settlement resolving allegations that the medical device company had misled consumers about the safety, efficacy, and effectiveness of its Infuse® Bone Graft Device (“Infuse”). The settlement represents continued coordination among States to prosecute marketing fraud and false advertising within the medical device industry.


Menu Title